Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChill Brands Regulatory News (CHLL)

Share Price Information for Chill Brands (CHLL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.50
Bid: 2.30
Ask: 2.70
Change: -0.20 (-8.00%)
Spread: 0.40 (17.391%)
Open: 2.50
High: 2.50
Low: 2.30
Prev. Close: 2.50
CHLL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of Dispensary Sales Pilot Programme

12 Oct 2022 08:00

RNS Number : 6172C
Chill Brands Group PLC
12 October 2022
 

12 October 2022

Chill Brands Group plc

("Chill Brands" or the "Company")

 

Launch of Dispensary Sales Pilot Programme

Chill Brands Group, the international consumer packaged goods company, is pleased to announce the launch of its CBD products into select cannabis dispensaries as part of a new sales pilot programme.

The pilot scheme will see Chill Brands' products enter an initial 20 fully licensed dispensaries as the Company gathers sales data and customer insights. Additional locations will be onboarded during Q4 2022. Following the completion of this pilot phase, the Company intends to scale its dispensary sales to additional locations across the United States.

During 2021, dispensaries in Colorado alone generated in excess of US $2 billion from sales of cannabis-based products. Consumers that frequent these stores typically have higher levels of discretionary income than convenience store shoppers, are already aware of and interested in cannabinoids including CBD, and are open to trialing new brands and products. They are supported by expert sales personnel known as 'budtenders', who act as cannabis sommeliers to guide consumers towards suitable products.

The programme will be launched in conjunction with Bellator and Dyspense, both Colorado-based sales and retail logistics companies with specific expertise in cannabis products.

Further updates will be provided as the pilot scheme progresses.

Timothy Ruybal Jr., Founder of Dyspense Technologies, commented:

"Dyspense looks forward to the launch of the Chill brand into Colorado dispensaries, where we have seen a steep increase in CBD only product sales over the last 24 month. Chill products provide a unique alternative for tobacco and THC consumers and we look forward to working with the Company to expand its footprint."

Callum Sommerton, Chief Executive Officer of Chill Brands, commented:

"We are excited to be expanding our US retail distribution footprint once more. This pilot programme is an opportunity to diversify the sales venues in which Chill products can be found. As demand for novel, non-psychoactive products continues to grow, we will be well positioned to offer Chill CBD to target consumers both to complement their cannabis purchases and as a non-intoxicating recreational alternative to THC.

We are grateful to our partners at Bellator and Dyspense for their support, and look forward to working with these industry experts as we seek to scale our operations within the dispensary environment."

-ENDS-

About Chill Brands Group

Chill Brands Group plc (LSE: CHLL, OTCQB: CHBRF) is an international company concerned with the development, production, and distribution of best-in-class hemp-derived CBD products, tobacco alternatives and other consumer packaged goods (CPG) products. The Company operates primarily in the US, where its products are distributed online and via some of the nation's most recognisable convenience retail outlets. The Group's strategy is anchored around lifestyle marketing that is designed to enhance the popularity of its products, channelling visitors to its landmark chill.com website.

Publication on website

A copy of this announcement is also available on the Group's website at http://www.chillbrandsgroup.com

Media enquiries:

Chill Brands Group plc

contact@chillbrandsgroup.com

Allenby Capital Limited (Financial Adviser and Broker)

+44 (0) 20 3328 5656

Nick Harriss/Nick Naylor (Corporate Finance)

Kelly Gardiner (Equity Sales)

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABKBBBABDKQKD
Date   Source Headline
23rd Sep 20228:00 amRNSUK Marketing Partnership
13th Sep 20224:41 pmRNSSecond Price Monitoring Extn
13th Sep 20224:36 pmRNSPrice Monitoring Extension
1st Sep 20223:45 pmRNSNotice of AGM
18th Aug 20227:00 amRNSAgreement for CBD Distribution Support
17th Aug 20224:41 pmRNSSecond Price Monitoring Extn
17th Aug 20224:35 pmRNSPrice Monitoring Extension
3rd Aug 20227:00 amRNSUpdate on Synthetic Nicotine Products
29th Jul 20225:00 pmRNSTotal Voting Rights & Holdings in the Company
13th Jul 20224:40 pmRNSSecond Price Monitoring Extn
13th Jul 20224:35 pmRNSPrice Monitoring Extension
4th Jul 20221:00 pmRNSIssue of Equity
30th Jun 20225:00 pmRNSTotal Voting Rights
23rd Jun 20227:00 amRNSAcquisition of Chill.com Domain Complete
21st Jun 20227:00 amRNSAdmission of New Shares & Total Voting Rights
17th Jun 20222:30 pmRNSResult of Open Offer
31st May 20225:00 pmRNSTotal Voting Rights
31st May 20227:00 amRNSOpen Offer to Shareholders
27th May 20225:30 pmRNSIssue of Equity
12th May 202210:17 amRNSResult of General Meeting
12th May 20229:30 amRNSBusiness Update
9th May 20227:00 amRNSProposed Open Offer
29th Apr 20225:30 pmRNSTotal Voting Rights
29th Apr 202211:00 amRNSPrice Monitoring Extension
27th Apr 20222:06 pmRNSSecond Price Monitoring Extn
27th Apr 20222:00 pmRNSPrice Monitoring Extension
26th Apr 20224:36 pmRNSCompany Raises £3.5m & Notice of GM
22nd Apr 202211:05 amRNSSecond Price Monitoring Extn
22nd Apr 202211:00 amRNSPrice Monitoring Extension
21st Apr 20227:00 amRNSIssue of Shares to Marketing Partner
20th Apr 20227:30 amRNSIssue of Shares to Director
19th Apr 20224:35 pmRNSPrice Monitoring Extension
19th Apr 20227:00 amRNSAppointment of CEO & Board Changes
4th Apr 20222:05 pmRNSSecond Price Monitoring Extn
4th Apr 20222:00 pmRNSPrice Monitoring Extension
22nd Mar 20224:41 pmRNSSecond Price Monitoring Extn
22nd Mar 20224:36 pmRNSPrice Monitoring Extension
15th Mar 20227:00 amRNSUpdate re Outstanding Promissory Note
14th Mar 202211:05 amRNSSecond Price Monitoring Extn
14th Mar 202211:00 amRNSPrice Monitoring Extension
9th Mar 202211:05 amRNSSecond Price Monitoring Extn
9th Mar 202211:00 amRNSPrice Monitoring Extension
4th Mar 20224:41 pmRNSSecond Price Monitoring Extn
4th Mar 20224:36 pmRNSPrice Monitoring Extension
4th Mar 20227:30 amRNSTrading Update
9th Feb 20228:00 amRNSChill Partners with Micro-Fulfilment Provider
7th Feb 20229:15 amRNSHolding(s) in Company
1st Feb 20227:00 amRNSHolding(s) in Company
31st Jan 20224:41 pmRNSSecond Price Monitoring Extn
31st Jan 20224:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.